|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/29/21 Gritstone bio, Inc. 8-K:1,2,8,9 9/21/21 13:10M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 40K 2: EX-10.1 Material Contract HTML 579K 3: EX-10.2 Material Contract HTML 24K 4: EX-10.3 Material Contract HTML 21K 9: R1 Document And Entity Information HTML 48K 11: XML IDEA XML File -- Filing Summary XML 12K 8: XML XBRL Instance -- grts-20210921_htm XML 16K 10: EXCEL IDEA Workbook of Financial Reports XLSX 6K 6: EX-101.LAB XBRL Labels -- grts-20210921_lab XML 42K 5: EX-101.PRE XBRL Presentations -- grts-20210921_pre XML 33K 7: EX-101.SCH XBRL Schema -- grts-20210921 XSD 11K 12: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K 13: ZIP XBRL Zipped Folder -- 0000950170-21-001926-xbrl Zip 158K
| EX-10.3 |
Exhibit 10.3
Third Amendment to License Agreement
This Third Amendment to License Agreement (“Third Amendment”) is made as of September 21, 2021, by and between Gritstone bio, Inc. (f/k/a Gritstone Oncology, Inc.) (“Licensee”) and MIL 21E, LLC (“Licensor”).
WHEREAS, Licensor and Licensee are parties to a certain License Agreement dated September 6, 2018, as amended by that certain First Amendment to License Agreement dated July 11, 2019, as amended by that certain Second Amendment to License Agreement date May 20, 2020 (collectively, “License Agreement”);
WHEREAS, Licensee warrants and represents that, to the best of its knowledge, Licensor has fulfilled its obligations under the License Agreement and is not in default of any covenants or obligations contained in the License Agreement;
WHEREAS, Licensor and Licensee desire to amend the License Agreement in certain respects as set forth herein; and,
WHEREAS, all capitalized terms contained herein shall, unless otherwise defined in this Third Amendment, have the same meaning as set forth in the License Agreement.
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree that the License Agreement is hereby amended as follows:
The Term of the Agreement shall be extended by five (5) months (“Third Extended Term”). The Third Extended Term shall commence on September 1, 2022 (“Third Extended Term Commencement Date”) and shall expire on January 31, 2023 (“Expiration Date”).
In consideration of the Third Extended Term Section 2(c) is hereby deleted in its entirety.
Effective the Third Extended Term Commencement Date, Licensee shall pay Licensor a monthly license fee of $375,926.70 (“Third Extended Term License Fee”), as shown on Schedule A attached hereto. Except as expressly stated otherwise herein, the Third Extended Term License Fee shall be subject to all the same terms and conditions as the License Fee.
Licensee shall pay to Licensor, immediately upon executing this Third Amendment, an amount equal to the Extended Term License Fee for the last month of the Extended Term ($375,926.70) (“Last Month Fee”). As Licensee has already paid $296,145.26 toward the last month’s payment for the current term, the balance owed pursuant to this Third Amendment is $79,781.44. Licensee shall also pay, immediately upon executing this Third Amendment, a Security Deposit equal to the Last Month Fee. As Licensee has already paid $296,145.26 toward the Security Deposit, the balance owed pursuant to this Third Amendment is $79,781.44. As such, Licensee shall pay Licensor a total of $159,562.88 on or before the execution of this Third Amendment.
IN WITNESS WHEREOF, Licensor and Licensee have duly executed this Third Amendment as of the date first written above.
LICENSOR: MIL 21E, LLC
/s/ Brian Taylor |
|
LICENSEE: Gritstone bio, Inc.
/s/ Andrew Allen |
By: Brian Taylor Title: Head of Field Operations Sep 22, 2021 |
|
By: Andrew Allen Title: President & CEO |
SCHEDULE A
Start |
End |
License Fee |
06/01/21 |
08/31/21 |
$ 287,519.67 |
09/01/21 |
08/31/22 |
$ 296,145.26 |
09/01/22 |
01/31/23 |
$ 375,926.70 |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 1/31/23 | ||||
| 9/1/22 | ||||
| Filed on: | 9/29/21 | |||
| For Period end: | 9/21/21 | SC 13G | ||
| 5/20/20 | ||||
| 7/11/19 | 8-K | |||
| 9/6/18 | CORRESP | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/05/24 Gritstone bio, Inc. 10-K 12/31/23 91:17M Donnelley … Solutions/FA 3/09/23 Gritstone bio, Inc. 10-K 12/31/22 88:20M Donnelley … Solutions/FA 3/10/22 Gritstone bio, Inc. 10-K 12/31/21 86:18M Donnelley … Solutions/FA 11/03/21 Gritstone bio, Inc. 10-Q 9/30/21 71:11M Donnelley … Solutions/FA 10/29/21 Gritstone bio, Inc. 424B5 1:192K Donnelley … Solutions/FA 10/29/21 Gritstone bio, Inc. S-3/A 2:261K Donnelley … Solutions/FA 10/15/21 Gritstone bio, Inc. S-3 3:301K Donnelley … Solutions/FA |